Bambino Gesù Children's Hospital, Rome, Italy, Piazza S. Onofrio n. 4, 00165, Rome, Italy.
Fondazione Policlinico Universitario A. Gemelli, Università Cattolica Sacro Cuore, Rome, Italy.
Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3.
The primary purpose of these practical guidelines related to Kawasaki disease (KD) is to contribute to prompt diagnosis and appropriate treatment on the basis of different specialists' contributions in the field. A set of 40 recommendations is provided, divided in two parts: the first describes the definition of KD, its epidemiology, etiopathogenetic hints, presentation, clinical course and general management, including treatment of the acute phase, through specific 23 recommendations.Their application is aimed at improving the rate of treatment with intravenous immunoglobulin and the overall potential development of coronary artery abnormalities in KD. Guidelines, however, should not be considered a norm that limits treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or complications.
本《川崎病实用指南》的主要目的是在不同领域专家贡献的基础上,促进川崎病的快速诊断和合理治疗。本指南共提供 40 条推荐意见,分为两部分:第一部分描述了川崎病的定义、流行病学、病因发病机制提示、表现、临床病程和一般管理,包括急性期的治疗,通过 23 条具体推荐意见来实现。应用这些推荐意见的目的是提高川崎病患儿接受静脉注射免疫球蛋白治疗的比例,以及整体上降低川崎病冠状动脉异常的发生率。然而,本指南不应被视为限制儿科医生和临床医生治疗选择的规范,因为可能需要根据特殊的医疗情况、患者病情、疾病严重程度或并发症等因素,选择推荐意见以外的治疗方式。